Semaglutide is a long-acting GLP-1 receptor agonist approved as Wegovy for weight management and as Ozempic for type 2 diabetes.
What Medical Assistance still pays for
Pennsylvania's November 2025 bulletin did three things from January 1, 2026: it ended GLP-1 coverage for overweight and obesity, removed Saxenda for all indications, and required prior authorization for other GLP-1 uses. Non-GLP-1 obesity drugs such as phentermine remain covered [2]. If you have type 2 diabetes and Medical Assistance, ask your prescriber to file the prior authorization for Ozempic, which is approved for diabetes [6].
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Pittsburgh, from $300 a month.
The listing shown here is a sponsored placement and is labeled. It is not chosen or reviewed by our editors.
Cash prices
| Product | Monthly price | Source |
|---|---|---|
| Wegovy pill, 1.5 mg / 4 mg / 9 and 25 mg | $149 / $199 / $299 | [1] |
| Wegovy pen, standard doses | $349 | [1] |
| Wegovy pen, first two low-dose fills (new patients) | $199 | [1] |
| Ozempic, 0.25 to 1 mg | $349 | [7] |
With a median household income of $65,742 in the city [4], a year of the Wegovy pen at $349 a month ($4,188) is about 6.4% of income. The 25 mg pill at $299 a month is $3,588 a year [1].
Diabetes in Allegheny County
CDC's latest county figures for Allegheny, from 2022 data, show 11.0% of adults with diagnosed diabetes [3]. The UPMC Center for Obesity Medicine lists medicine as part of treatment [5]. See Ozempic vs Wegovy for which label applies.
If you are offered compounded semaglutide
If you are offered it, know that compounded semaglutide is not FDA-approved and that FDA does not review compounded drugs for safety, effectiveness or quality [11]. FDA says 503B outsourcing facilities cannot compound semaglutide from bulk ingredients because it is neither on the 503B bulks list nor in shortage [8]. FDA has warned telehealth firms against calling compounded drugs "generic" or "the same as" an approved drug [9]. See compounded semaglutide.
Elsewhere in the region
Compare Baltimore, New Jersey and New York City, or read where to get semaglutide and medical weight loss in Pittsburgh.
Watch for these
Get care for severe stomach pain that does not stop, which can be pancreatitis [10] [6]. Semaglutide has a boxed warning about thyroid C-cell tumors and is not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Hypoglycemia becomes more likely when semaglutide is paired with insulin or a sulfonylurea. Seek urgent help for facial swelling or trouble breathing. If you become pregnant, the Wegovy label says to discontinue it. Call 911 in an emergency.
Questions people ask
Does Pennsylvania Medicaid cover Ozempic for diabetes?
Since January 1, 2026, Medical Assistance requires prior authorization for GLP-1 uses other than obesity, such as diabetes [2].
Does Pennsylvania Medicaid cover Wegovy for weight loss?
No. Medical Assistance ended GLP-1 coverage for overweight and obesity on January 1, 2026 [2].
How much is semaglutide in Pittsburgh without insurance?
NovoCare self-pay is $149 to $299 a month for the Wegovy pill and $349 for the Wegovy pen, checked Oct 17, 2026 [1].
Is phentermine still covered by Pennsylvania Medicaid?
Yes. The November 2025 bulletin keeps non-GLP-1 obesity drugs such as phentermine covered [2].
Can outsourcing facilities make compounded semaglutide?
FDA says 503B facilities cannot compound semaglutide from bulk because it is not on the 503B bulks list and is not in shortage [8].
Sources
11 cited
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Medical Assistance Bulletin: GLP-1 coverage for weight loss. Pennsylvania Department of Human Services, Nov 24, 2025.
- PLACES data, county, 2024 release: Allegheny County, PA. Centers for Disease Control and Prevention, 2024 release (2022 BRFSS).
- QuickFacts: Pittsburgh city, Pennsylvania. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Center for Obesity Medicine. UPMC, accessed 2026-10-17.
- Ozempic label. DailyMed, National Library of Medicine, May 2026.
- Ozempic self-pay pricing, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. U.S. Food and Drug Administration, Apr 1, 2026.
- FDA: what telehealth companies should know when promoting compounded drugs. U.S. Food and Drug Administration, Jun 15, 2026.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Compounding and the FDA: questions and answers. U.S. Food and Drug Administration, 2025-09-16 (accessed 2026-10-17).
This page is general information, not medical advice. Talk with a licensed clinician about your own care.